Drugs & Therapy Perspectives

, Volume 30, Issue 4, pp 141–146

Consider switching to another disease-modifying therapy when unacceptable disease activity occurs in relapsing multiple sclerosis

Disease Management

DOI: 10.1007/s40267-013-0086-0

Cite this article as:
Adis Medical Writers Drugs Ther Perspect (2014) 30: 141. doi:10.1007/s40267-013-0086-0
  • 59 Downloads

Abstract

Several disease-modifying therapies with distinct mechanisms of action are currently approved for the treatment of relapsing forms of multiple sclerosis. Switching to treatment with a different disease-modifying agent is a common approach when a patient experiences unacceptable breakthrough disease activity. Several practical points and suggestions for switching therapy in such patients are proposed.

Copyright information

© Springer International Publishing Switzerland 2013

Authors and Affiliations

  1. 1.AdisNorth ShoreNew Zealand

Personalised recommendations